ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) Investor Alert: Lawsuit Alleges False Statements
A lawsuit was filed for certain investors in shares of ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) over alleged securities laws violations. Deadline: February 26, 2013. NASDAQ:ISIS investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com
View full press release